These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7479217)

  • 1. [The effect of short-term erythropoietin therapy on selected parameters of cell mediated and humoral immunity in hemodialyzed uremic patients].
    Wiecek A; Kyrcz-Krzemień S; Franek E; Kokot F; Hołowiecki J; Klin M
    Pol Arch Med Wewn; 1995 Jan; 93(1):41-7. PubMed ID: 7479217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis.
    Díez JJ; Iglesias P; Sastre J; Aguilera A; Bajo MA; Méndez J; Gómez Pan A; Selgas R
    Metabolism; 1999 Feb; 48(2):210-6. PubMed ID: 10024084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved immunoglobulin production in dialysis patients treated with recombinant erythropoietin.
    Schaefer RM; Paczek L; Berthold G; Gilge U; Heidland A
    Int J Artif Organs; 1992 Apr; 15(4):204-8. PubMed ID: 1587641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of recombinant human erythropoietin on apoptosis and cytokine production of CD4+ lymphocytes from hemodialyzed patients.
    Lisowska KA; Dębska-Ślizień A; Jasiulewicz A; Daca A; Bryl E; Witkowski JM
    J Clin Immunol; 2013 Apr; 33(3):661-5. PubMed ID: 23180360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte subsets in hemodialysis patients treated with recombinant human erythropoietin.
    Ueki Y; Nagata M; Miyake S; Tominaga Y
    J Clin Immunol; 1993 Jul; 13(4):279-87. PubMed ID: 7901232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of long-term erythropoietin treatment on plasma levels of calcium-phosphate related hormones in haemodialyzed uraemic patients.
    Kokot F; Wiecek A; Marcinkowski W; Schmidt-Gayk H; Rudka R; Trembecki J
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():9-16. PubMed ID: 8192535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes.
    Lisowska KA; Debska-Slizien A; Radzka M; Witkowski JM; Rutkowski B; Bryl E
    Artif Organs; 2010 Mar; 34(3):E77-84. PubMed ID: 20447038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin, folic acid deficiency and hyperhomocysteinemia: is there a possible relationship in chronically hemodialyzed patients?
    Korzets A; Ori Y; Chagnac A; Weinstein T; Herman M; Zevin D; Malachi T; Gafter U
    Clin Nephrol; 2000 Jan; 53(1):48-54. PubMed ID: 10661482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acute effect of intravenously administered recombinant human erythropoietin on the immune response of uremic patients maintained on regular hemodialysis.
    William J; Saad N; Salib M; Riad H; Mahran KS; Iskander I; Cozma G; Barsoum R
    Artif Organs; 1998 Mar; 22(3):192-6. PubMed ID: 9527278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin (rhEPO) treatment potentiates growth hormone (GH) response to growth hormone releasing hormone (GHRH) stimulation in hemodialysis patients.
    Cremagnani L; Cantalamessa L; Orsatti A; Vigna L; Vallino F; Buccianti G
    Clin Nephrol; 1993 May; 39(5):282-6. PubMed ID: 8513607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Numerical and functional alterations in T and B lymphocyte subpopulations in CAPD patients treated with recombinant human erythropoietin].
    Tanabe R
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1159-68. PubMed ID: 7815748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis.
    Németh I; Túri S; Haszon I; Bereczki C
    Pediatr Nephrol; 2000 Jan; 14(1):13-7. PubMed ID: 10654322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy.
    Costa E; Lima M; Alves JM; Rocha S; Rocha-Pereira P; Castro E; Miranda V; do SF; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
    J Clin Immunol; 2008 May; 28(3):268-75. PubMed ID: 18205031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant human erythropoietin and interleukin-3 on erythropoietic recovery from acute anemia.
    Rosen BS; Levine EA; Egrie JC; Sehgal LR; Greenberg R; Rosen AL; Levine HD; Gould SA
    Exp Hematol; 1993 Oct; 21(11):1487-91. PubMed ID: 8405228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.
    Frank H; Heusser K; Höffken B; Huber P; Schmieder RE; Schobel HP
    Kidney Int; 2004 Aug; 66(2):832-40. PubMed ID: 15253740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of recombinant human erythropoietin on serum selenium levels in hemodialysis patients.
    Celiker A; Giray B; Başay T; Oner L
    J Trace Elem Med Biol; 2001; 15(4):215-20. PubMed ID: 11846010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of human recombinant erythropoietin on levels of plasma phospholipids in patients chronically treated with hemodialysis].
    Krawczyk W; Dmoszyńska A; Ledwozyw A; Marczewski K
    Pol Arch Med Wewn; 1995 Jul; 94(1):21-5. PubMed ID: 8524695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
    Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
    Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin stimulates production of interleukin 2 by whole blood cell cultures of hemodialysis patients.
    Bryl E; Myśliwska J; Debska-Slizień A; Trzonkowski P; Rachoń D; Bułło B; Zdrojewski Z; Myśliwski A; Rutkowski B
    Artif Organs; 1999 Sep; 23(9):809-16. PubMed ID: 10491027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of STAT5 phosphorylation and CD95 expression in CD4+ T lymphocytes treated with recombinant human erythropoietin.
    Lisowska KA; Dębska-Ślizień A; Jasiulewicz A; Jóźwik A; Rutkowski B; Bryl E; Witkowski JM
    J Recept Signal Transduct Res; 2011 Jun; 31(3):241-6. PubMed ID: 21619451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.